Analysts expect Credit Acceptance to report an earnings per share (EPS) of $9.67. Anticipation surrounds Credit Acceptance's ...

Patients with IBD treated with the original adalimumab reference product show a high acceptance of the switch to its ...

Investors search for underpriced tokens with great future development potential. Rexas Finance (RXS), Ripple (XRP), and ...

In today's fast-paced world, gardening emerges as a potent tool for self-discovery and enhanced well-being. Beyond a relaxing hobby, it cultivates a growth mindset, teaching resilience through ...

SHANGHAI & CAMBRIDGE, Mass., April 21, 2025--(BUSINESS WIRE)--Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that China’s National Medical Products Administration (NMPA) has accepted ...

Selena Gomez has shared the real reason for launching makeup brand at the Rare Beauty’s 4th annual Mental Health Summit.The ...

Final court decisions in 730 days, down from the current 1,492 — The judge will carry out a file check so that cases are ...

Novel study examined narrative self-transcendence in the life stories of a group of late-midlife adults shared over eight ...

Repotrectinib has the potential to become a next-generation TKI that can be used across a broad range of NTRK fusion-positive solid tumors in both settings. In June 2024, AUGTYRO (repotrectinib ...

"NTRK fusion-positive tumors represent a significant therapeutic challenge, particularly in the setting of acquired resistance to existing TRK tyrosine kinase inhibitors (TKIs)," said Dr. Rafael Amado ...